Acumen Capital Forecasts Strong Price Appreciation for Calian Group (TSE:CGY) Stock

Calian Group (TSE:CGY) had its target price hoisted by investment analysts at Acumen Capital from C$70.00 to C$85.00 in a research report issued to clients and investors on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Acumen Capital’s price target indicates a potential upside of 20.40% from the company’s current price.

Several other research firms have also recently commented on CGY. Royal Bank Of Canada raised their target price on shares of Calian Group from C$58.00 to C$60.00 and gave the stock an “outperform” rating in a research note on Friday. Ventum Financial boosted their target price on Calian Group from C$62.00 to C$72.00 and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Canadian Imperial Bank of Commerce lifted their price target on Calian Group from C$65.00 to C$76.00 in a research note on Friday. Desjardins upped their price objective on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a report on Thursday, November 27th. Finally, Canaccord Genuity Group boosted their target price on shares of Calian Group from C$63.00 to C$80.00 in a research report on Friday. Six equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of C$74.83.

Calian Group Stock Up 6.7%

Calian Group stock opened at C$70.60 on Friday. The stock has a 50 day moving average of C$60.38 and a two-hundred day moving average of C$54.13. Calian Group has a twelve month low of C$37.70 and a twelve month high of C$71.92. The stock has a market capitalization of C$805.62 million, a price-to-earnings ratio of 40.11, a PEG ratio of 2.50 and a beta of 0.70. The company has a current ratio of 1.29, a quick ratio of 1.20 and a debt-to-equity ratio of 39.54.

Calian Group (TSE:CGY) last released its quarterly earnings results on Thursday, February 12th. The company reported C$1.03 EPS for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%.The business had revenue of C$208.00 million during the quarter. As a group, research analysts expect that Calian Group will post 4.9475219 earnings per share for the current year.

Trending Headlines about Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.